Previous 10 | Next 10 |
2024-04-09 08:59:00 ET U.S. stock index futures on Tuesday pointed to a slightly higher open, a day ahead of a key consumer inflation report. Here are some stocks to watch on Tuesday: ... Read the full article on Seeking Alpha For further details see: 4 stocks to wa...
2024-04-09 08:13:22 ET More on Alkermes Alkermes plc 2023 Q4 - Results - Earnings Call Presentation Alkermes plc (ALKS) Q4 2023 Earnings Call Transcript Alkermes: Additional Narcolepsy Data Could Lead The Way To The Next Stage Baird starts Alkermes at outperf...
Alkermes Announces Positive Topline Results From Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients With Narcolepsy Type 2 and Idiopathic Hypersomnia PR Newswire — Orexin 2 Receptor Agonist ALKS 2680 Demonstrated Clinically Meaningful and Statist...
Alkermes Presents Analyses From Long-Term Safety Study of LYBALVI® (olanzapine and samidorphan) at 2024 Congress of the Schizophrenia International Research Society PR Newswire DUBLIN , April 8, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today anno...
2024-03-20 14:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-19 14:37:43 ET More on Alkermes Alkermes plc 2023 Q4 - Results - Earnings Call Presentation Alkermes plc (ALKS) Q4 2023 Earnings Call Transcript Alkermes: Additional Narcolepsy Data Could Lead The Way To The Next Stage Alkermes downgraded at UBS as st...
2024-03-18 14:07:39 ET Summary The healthcare sector is overvalued by about 13% relative to 11-year averages, but overvaluation varies a lot across subsectors. Healthcare equipment has the worst value and quality scores. iShares Global Healthcare ETF is a global alternative to...
Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors PR Newswire DUBLIN , March 7, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced the appointment of a new independent director, Nancy S. Lurker, to the company's Board of Di...
2024-02-21 13:04:28 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biotech stocks are often at the forefront of innovation. These are the companies we hear about that are driving breakthroughs in healthcare. Essentially, they are responsible for improving ...
2024-02-20 12:32:42 ET More on Alkermes Alkermes: Additional Narcolepsy Data Could Lead The Way To The Next Stage Alkermes to sell Athlone facility in Ireland to Novo Nordisk for $92.5M Alkermes Q4 2023 Earnings Preview Alkermes plc 2023 Q4 - Results - Earnin...
News, Short Squeeze, Breakout and More Instantly...
Alkermes plc Company Name:
ALKS Stock Symbol:
NASDAQ Market:
Alkermes plc Completes Sale of Athlone, Ireland Facility to Novo Nordisk PR Newswire DUBLIN , May 2, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) has completed the previously announced sale of its development and manufacturing facility in Athlone, Irela...
Enact Holdings Inc. (ACT) is expected to report $0.99 for Q1 2024 FormFactor Inc. (FORM) is expected to report $0.09 for Q1 2024 SAAB AB - Class B (SAABF) is expected to report for quarter end 2024-03-31 Lumos Pharma Inc. (LUMO) is expected to report $-1.21 for Q1 2024 Axis Capita...
Alkermes Announces Initiation of Vibrance-1 Phase 2 Study Evaluating ALKS 2680 for the Treatment of Narcolepsy Type 1 PR Newswire DUBLIN , April 24, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced initiation of the Vibrance-1 study, a pha...